As demonstrated in Fig. 4A, we found that AKT1, TP53, CTNNB1, STAT3, EGFR, VEGFA, PIK3CA, ERBB2, and HIF1A were strongly expressed in GBM and LGG, particularly in GBM. This evidence concerns the gene ERBB2 and glioblastoma.